English - helena BioSciences SAS-1 Pentavalent Screen Instrucciones De Uso

I I N N T T E E N N D D E E D D P P U U R R P P O O S S E E
The SAS-1 Pentavalent Screen Kit is intended for the screening of serum and urine samples for
monoclonal gammopathies, by agarose gel electrophoresis and immunofixation.
Immunofixation electrophoresis (IFE) is a two stage procedure using high resolution agarose
electrophoresis in the first stage, and immunoprecipitation in the second phase.
The greatest demand for IFE is in the clinical laboratory, where it is used primarily for the detection of
monoclonal gammopathies. A monoclonal gammopathy is a primary disease state in which a single
clone of plasma cells produce elevated levels of an immunoglobulin of a single class and type.
Such immunoglobulins are referred to as monoclonal proteins, M-proteins or paraproteins.
Their presence may be of a benign nature or of uncertain significance. In some cases, they are
indicative of a malignancy, such as multiple myeloma or Waldenström's macroglobulinaemia.
Differentiation must be made between polyclonal and monoclonal gammopathies, as polyclonal
gammopathies are a secondary disease state due to clinical disorders such as chronic liver disease,
collagen disorders, rheumatoid arthritis and chronic infection.
Urinary proteins are derived primarily from plasma proteins that filter through the kidney.
The appearance of abnormal plasma proteins in the urine is of great value in evaluating renal function.
The appropriate study of proteinuria should include quantitative and qualitative assessment of the type
and amount of proteins excreted
Alfonso first described immunofixation in the literature in 1964
practical procedure in 1969, and published a number of studies utilising this technique
Immunofixation has been used as a procedure for the investigation of immunoglobulins since 1976
W W A A R R N N I I N N G G S S A A N N D D P P R R E E C C A A U U T T I I O O N N S S
All reagents are for in-vitro diagnostic use only. Do not ingest or pipette by mouth any kit component.
Wear gloves when handling all kit components. Refer to the product safety data sheet for risk and
safety phrases and disposal information.
C C O O M M P P O O S S I I T T I I O O N N
2 2 0 0 0 0 3 3 0 0 1 1 : :
1 1 . . S S A A S S - - 1 1 G G e e l l
Contains agarose in a Tris / Barbital buffer with thiomersal and sodium azide as preservative.
The gel is ready for use as packaged.
2 2 . . A A c c i i d d V V i i o o l l e e t t S S t t a a i i n n C C o o n n c c e e n n t t r r a a t t e e
NOT FOR USE WITH THE PENTAVALENT SCREEN KIT.
3. Destain Solution Concentrate
Contains concentrated Destain Solution. Dilute the contents of the bottle to 2 litres with purified
water. Store in a tightly stoppered bottle.
4 4 . . W W a a s s h h S S o o l l u u t t i i o o n n
Contains 100ml of concentrated Wash Solution. Dilute 20ml to 1 litre with saline solution.
5. Sample Diluent
Contains Tris / Barbital buffer with bromophenol blue and sodium azide as preservative.
The diluent is ready for use as packaged.
1-5
.
1
SAS-1 PENTAVALENT SCREEN
6
. Alper and Johnson published a more
7-9
.
10-11
.

English